Monro Inc. logo MNRO - Monro Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 9
HOLD 15
SELL 0
STRONG
SELL
0
| PRICE TARGET: $16.50 DETAILS
HIGH: $17.00
LOW: $16.00
MEDIAN: $16.50
CONSENSUS: $16.50
UPSIDE: 33.12%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 80% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Undervalued Moderate
Trading 32.0% below fair value
Current Price $12.39
Bear Case $15.96 28.8% upside ($15.96 - $12.39) / $12.39 = 28.8% $1.14 × 14x P/E
Fair Value $18.24 47.2% upside ($18.24 - $12.39) / $12.39 = 47.2% $1.14 × 16x P/E
Bull Case $20.52 65.6% upside ($20.52 - $12.39) / $12.39 = 65.6% $1.14 × 18x P/E

Adjust Assumptions

16.0x
1.14$

Key Value Driver

Normalized P/E multiple (16x base case)

Implied Market Multiple 10.9x

Plain-Language Summary

Applying a 16x P/E to adjusted EPS of $1.14, the base-case value is $18.24 per share. DDM cross-check: $16.16.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (24 analysts) $16.50
Analyst Range $16.00 – $17.00
Divergence from AlphaVal 11%

Warnings

The company's reported profits differ from official accounting profits by 4045%. Check what costs are being left out of the adjusted number.
The company pays out 4073% of its profits as dividends. That leaves little cushion — the dividend could be cut if business slows down.
This stock is 48% below its 52-week high, with weak or declining earnings. That combination often signals real trouble, even though the valuation below is based on other fundamentals.

Key Risks

  • Growth DCF inappropriate — terminal value assumptions dominate
  • EV/EBITDA misleading for regulated businesses where capex is mandated
  • Regulatory risk is a fat tail not visible in normal multiples